Intellectual property firm KIPA is shifting its focus back to medical devices following the COVID-19 outbreak.
The company has recognised the increased interest in developing medical technologies and is inviting any developers who need help with securing the intellectual property side.
KIPA has 13 years of experience in the space and handles cases for clients ranging from startups to major industries and universities.
Erik Krahbichler, CEO, said: “We look forward to assist our existing and future clients in these challenging times. Strong IP protection has proven to support and strengthen the development of medical devices. This is for sure also valid for medical devices assisting COVID-19 patients and to fight the Coronavirus globally.”
